We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Globalisation and Expansion

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: 1 minute
Sciformix has recently expanded with the opening of a UK based facility, leading to a presence in three continents.
We spoke to Manish Soman, CEO at Sciformix Corporation, to find out more about the services Sciformix offers, and how this expansion will benefit its customers.

AM: Can you tell us a little about Sciformix and the services it offers?

MS: Sciformix provides high quality scientific knowledge-based services across the areas of Safety & Risk Management, Clinical Research & Post-Approval Support and Regulatory Affairs & Operations to pharmaceutical, biopharmaceutical and generics companies as well as to consumer products, medical device and other healthcare companies. We partner with global life science companies to help deliver better quality outcomes and improved efficiencies across the entire product lifecycle, with the ultimate objective of improving quality of healthcare for patients worldwide.

AM: Sciformix recently opened an office in the UK. What led to this expansion?

MS: The opening of the UK office demonstrates our scalability and preparedness to combine optimized on-shore/off-shore models that enhance the client value and experience while maximizing cost benefits. Sciformix’s expansion into Europe complements our already established presence in the United States and Asia. We will now be within arm’s reach of clients’ operations across 3 continents.

AM: How will this growth benefit Sciformix’s customers?

MS: With the new office, we will seek to better service our existing global and European clients with near-shore presence and also build new relationships with potential clients across Europe, Middle East and Africa (EMEA) to further grow and diversify our client and revenue base.

AM: Sciformix now has presence in three continents. Are there plans for further global development into other emerging markets?

MS: We are always looking to expand and will plan for further growth into other EU countries, Latin America and additional countries in Asia to continue to support our global clients and contribute to their organizational achievements. The long-term strategy for Sciformix focuses on evolving and enhancing our service and technology offerings. By broadening our global reach, growing and diversifying our client and revenue base, we are able to employ expert talent and processes, for those seeking to forge strategic outsourcing partnerships. With our clients’ ever increasing growth into emerging markets, it is increasingly more important for us to truly understand the local safety and regulatory challenges our clients face across all geographies and to become the partner of choice when it comes to outsourcing these activities.

To learn more about Sciformix visit www.sciformix.com, email us at ask@sciformix.com, or call us at +1.877.576.5005.

Manish.png

Manish Soman was speaking to Anna-Marie MacDonald, Editor for Technology Networks.